• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tempest Therapeutics Inc (NQ: TPST )

    2.850 -0.060 (-2.06%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 939,311
    Open 2.920
    Bid (Size) 3.950 (22)
    Ask (Size) 3.980 (22)
    Prev. Close 2.910
    Today's Range 2.830 - 3.000
    52wk Range 0.1700 - 9.770
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
    Webcasted conference call on Thursday, June 20, 2024 at 8:30 a.m. ET 
    From Tempest Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    -35.37%
    -35.37%
    1 Month
    -12.84%
    -12.84%
    3 Month
    -24.20%
    -24.20%
    6 Month
    -22.55%
    -22.55%
    1 Year
    +122.66%
    +122.66%

    More News

    Read More
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Tempest Therapeutics
    Via GlobeNewswire
    “Market Mavericks: Stocks Creating Ripples of Success” CLNV, TPST, HNRC, INPX
    Via AB Newswire
    Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Tempest to Participate in Upcoming Investor Conferences
    From Tempest Therapeutics
    Via GlobeNewswire
    TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
    From Tempest Therapeutics
    Via GlobeNewswire
    Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
    From Tempest Therapeutics
    Via GlobeNewswire
    TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Tempest Reports Year End 2023 Financial Results and Provides Business Update
    From Tempest Therapeutics
    Via GlobeNewswire
    Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Therapeutics Announces Groundbreaking Advances in Liver Cancer Treatment, Showcasing Exceptional Efficacy and Safety Data at ASCO Annual Meeting 2024
    Via AB Newswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Tempest Therapeutics
    Via GlobeNewswire
    Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
    From Tempest Therapeutics
    Via GlobeNewswire
    Intelligent Bio (NASDAQ: INBS) Surges Massively Among Stocks Making BUZZ:TPST, HNST, LTRN, VTAK
    Via AB Newswire
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.